AAAAAA
Results:
1-7
|
Results: 7
Authors:
Tahar, AH
Ekesbo, A
Gregoire, L
Bangassoro, E
Svensson, KA
Tedroff, J
Bedard, PJ
Citation: Ah. Tahar et al., Effects of acute and repeated treatment with a novel dopamine D-2 receptorligand on L-DOPA-induced dyskinesias in MPTP monkeys, EUR J PHARM, 412(3), 2001, pp. 247-254
Authors:
Tahar, AH
Gregoire, L
Bangassoro, E
Bedard, PJ
Citation: Ah. Tahar et al., Sustained cabergoline treatment reverses levodopa-induced dyskinesias in parkinsonian monkeys, CLIN NEUROP, 23(4), 2000, pp. 195-202
Authors:
Calon, F
Tahar, AH
Blanchet, PJ
Morissette, M
Grondin, R
Goulet, M
Doucet, JP
Robertson, GS
Nestler, E
Di Paolo, T
Bedard, P
Citation: F. Calon et al., Dopamine-receptor stimulation: biobehavioral and biochemical consequences, TRENDS NEUR, 23(10), 2000, pp. S92-S100
Authors:
Grondin, R
Tahar, AH
Doan, VD
Ladure, P
Bedard, PJ
Citation: R. Grondin et al., Noradrenoceptor antagonism with idazoxan improves L-dopa-induced dyskinesias in MPTP monkeys, N-S ARCH PH, 361(2), 2000, pp. 181-186
Authors:
Tahar, AH
Belanger, N
Bangassoro, E
Gregoire, L
Bedard, PJ
Citation: Ah. Tahar et al., Antidyskinetic effect of JL-18, a clozapine analog, in parkinsonian monkeys, EUR J PHARM, 399(2-3), 2000, pp. 183-186
Authors:
Doan, VD
Grondin, R
Tahar, AH
Gregoire, L
Bedard, PJ
Citation: Vd. Doan et al., Effect of the selective D-1 antagonists SCH 23390 and NNC 01-0112 on the delay, duration, and improvement of behavioral responses to dopaminergic agents in MPTP-treated monkeys, CLIN NEUROP, 22(5), 1999, pp. 281-287
Authors:
Grondin, R
Bedard, PJ
Tahar, AH
Gregoire, L
Mori, A
Kase, H
Citation: R. Grondin et al., Antiparkinsonian effect of a new selective adenosine A(2A) receptor antagonist in MPTP-treated monkeys, NEUROLOGY, 52(8), 1999, pp. 1673-1677
Risultati:
1-7
|